Ginsenoside Rg1 alleviates MAFLD by inhibiting oxidative stress and ferroptosis via the Nrf2/GPX4 pathway

Metabolic dysfunction-associated fatty liver disease (MAFLD) imposes a significant global health burden, and safe and effective treatments are still lacking. Ginsenoside Rg1 (Rg1), a key bioactive compound extracted from ginseng, can effectively alleviate liver injury associated with MAFLD, but the specific molecular mechanism remains unclear. This study aims to investigate the therapeutic effects of Rg1 on MAFLD and elucidate its underlying mechanisms. A mouse model was established using the methionine-choline-deficient (MCD) diet, and Rg1 was given intragastrically for 4 consecutive weeks. The effects of Rg1 on MAFLD were investigated in vitro by cultivating HepG2 cells with free fatty acids (FFA). We used commercial assay kits, histopathological staining, transmission electron microscopy (TEM), immunofluorescence (IF), polymerase chain reaction (PCR), and Western blotting (WB) to assess parameters related to inflammation, oxidative stress, and ferroptosis in liver tissue and HepG2 cells. Molecular docking, cellular thermal shift assay (CETSA), and the Nrf2 inhibitor (ML385) were used to validate the potential mechanisms underlying the hepatoprotective effects of Rg1. Rg1 treatment dramatically reduced hepatic Fe 2+ , oxidative stress, and inflammatory factor levels. In vitro experiments revealed that Rg1 reduced iron, MDA, and ROS levels, while upregulating SLC7A11 and GPX4 to inhibit oxidative stress and ferroptosis. These results suggest that Rg1 exerts antioxidant and antiferroptotic effects by activating the Nrf2/GPX4 signaling pathway. Rg1 is a natural bioactive compound with potential therapeutic applications for MAFLD; it attenuates MCD/FFA-induced hepatic injury by inhibiting oxidative stress and ferroptosis, at least partly through activation of the Nrf2/GPX4 pathway.

Authors

Institutions

Publication Details

Journal
European journal of medical research
Published
2026-11-15
DOI
https://doi.org/10.1186/s40001-026-05497-0
Primary Topic
Ginseng Biological Effects and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ginsenoside Rg1 alleviates MAFLD by inhibiting oxidative stress and ferroptosis via the Nrf2/GPX4 pathway

Peiyun Peng, Zi Wang, J Y Zhang, Kunli Yin et al.
8 links
European journal of medical research
Ginseng Biological Effects and Applications
article

Ginsenoside Rg1 alleviates MAFLD by inhibiting oxidative stress and ferroptosis via the Nrf2/GPX4 pathway

Peiyun Peng, Zi Wang, J Y Zhang, Kunli Yin, Wenxiang Huang
article en

Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) imposes a significant global health burden, and safe and effective treatments are still lacking. Ginsenoside Rg1 (Rg1), a key bioactive compound extracted from ginseng, can effectively alleviate liver injury associated with MAFLD, but the specific molecular mechanism remains unclear. This study aims to investigate the therapeutic effects of Rg1 on MAFLD and elucidate its underlying mechanisms. A mouse model was established using the methionine-choline-deficient (MCD) diet, and Rg1 was given intragastrically for 4 consecutive weeks. The effects of Rg1 on MAFLD were investigated in vitro by cultivating HepG2 cells with free fatty acids (FFA). We used commercial assay kits, histopathological staining, transmission electron microscopy (TEM), immunofluorescence (IF), polymerase chain reaction (PCR), and Western blotting (WB) to assess parameters related to inflammation, oxidative stress, and ferroptosis in liver tissue and HepG2 cells. Molecular docking, cellular thermal shift assay (CETSA), and the Nrf2 inhibitor (ML385) were used to validate the potential mechanisms underlying the hepatoprotective effects of Rg1. Rg1 treatment dramatically reduced hepatic Fe 2+ , oxidative stress, and inflammatory factor levels. In vitro experiments revealed that Rg1 reduced iron, MDA, and ROS levels, while upregulating SLC7A11 and GPX4 to inhibit oxidative stress and ferroptosis. These results suggest that Rg1 exerts antioxidant and antiferroptotic effects by activating the Nrf2/GPX4 signaling pathway. Rg1 is a natural bioactive compound with potential therapeutic applications for MAFLD; it attenuates MCD/FFA-induced hepatic injury by inhibiting oxidative stress and ferroptosis, at least partly through activation of the Nrf2/GPX4 pathway.

European journal of medical research
The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
Good health and well-being
Ginseng Biological Effects and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Ginsenoside Rg1 alleviates MAFLD by inhibiting oxidative stress and ferroptosis via the Nrf2/GPX4 pathway — Peiyun Peng, Zi Wang, et al. · European journal of medical research (2026) | TGRS Research Map | TGRS